Jarvis
  • CATEGORIES
    • Equity Market
    • Investing Basics
    • Interesting Read
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Newsletter
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner
No Result
View All Result
Jarvis
  • CATEGORIES
    • Equity Market
    • Investing Basics
    • Interesting Read
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Newsletter
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner
No Result
View All Result
Jarvis
No Result
View All Result
Home Newsletter

Tuesday, 22nd February 2022

by Sumit Chanda
February 22, 2022
in Newsletter
Reading Time: 4 mins read
A A
0
Share on FacebookShare on Twitter

Vedanta made an oil discovery in Barmer, Rajasthan as notified in its filing to the Directorate General of Hydrocarbons (DGH). This block was awarded to Vedanta under Open Acreage Licensing Policy (OALP). Vedanta holds 100% participating interest in the block and this is the 3rd hydrocarbon discovery notified by Vedanta under OALP portfolio. Currently, the company is carrying on evaluation to assess potential commerciality of the discovery. This is part of the oil blocks of Cairn India, which had sold out to Vedanta.

LIC is planning not to sell out its entire stake in IDBI Bank and would instead explore the possibility of using the bank’s massive network of branches to market its insurance products and solutions. LIC is planning to float 5% of its equity as an offer for sale to raise over Rs.65,000 crore before the end of FY22. This intent was revealed by the LIC Chairman, M R Kumar. Between the government of India and LIC, they jointly hold over 90% stake in IDBI Bank, which has a network of over 1,800 branches in India and assets of $39 billion.

As India approaches the end of FY22 and braces for the LIC IPO, there are more IPOs that got SEBI approval. PharmEasy, Wellness Forever and CMR Green Technologies are among the companies to have got SEBI approval for their IPOs. These companies had filed their DRHP with SEBI between Sep-21 and Nov-21 last year. While PharmEasy plans to raise a sum of Rs.6,250 crore, Wellness Forever will raise close to Rs.1,600 crore. CMR Green Technologies IPO will comprise of Rs.300 crore fresh issue plus 3.34 crore share via OFS. 

NTPC, India’s largest thermal power company, paid an interim dividend of Rs.3,879 crore for FY22. The dividend was nearly 40% of the share capital of NTPC. This was the 29th successive year NTPC has paid dividends. For the Dec-21 quarter, NTPC had reported 19.34% higher net profits at Rs.4,626 crore on total sales revenues of Rs.33,784 crore for the quarter. Its total power production for FY22 till date stood at 315 billion units (BU) surpassing the power generation of FY21. NTPC has installed capacity of 67,832 MW.

The same clinical laboratory stocks that virtually ruled the roost  during the COVID period, are looking for new sources of growth to fuel investor interest. The stock have seen their COVID-fuelled stock rallies falter in recent months. As outbreaks ease and countries look to reopen, these gains have started to fade for the clinical labs. Major players like Metropolis Healthcare and Dr Lal PathLabs missed analyst estimates. It is feared that many of these companies may face stress from expensive M&A at the peak of the cycle.

Government may propose a detailed formula to bring aviation turbine fuel (ATF) under GST. The GST Council is likely to allow 18% GST in addition  to state level VAT. This will be subject to approval of various states. VAT varies from state to state. There are global precedents for such a formula. There has been a strident demand by airlines, airline bodies and even the Ministry of Civil Aviation to put ATF under GST to provide relief to the already beleaguered airlines. Sharp fall in PLF has been the bane of airline companies.

Hyderabad-based Biological E Ltd has readied India’s third vaccine, Corbevax, for children aged 12 to 18. Currently, only children above 15 are being vaccinated and more than 7.6 crore children in this age group have been vaccinated. National Technical Advisory Group on Immunisation (NTAGI) ruled Corbevax as safe and offering good immunogenicity and higher antibody levels compared to other vector vaccines. Corbevax is a protein subunit vaccine. This had worked even on heterologous groups during clinical trials. 

Air passenger numbers are expected to cross pre-pandemic levels by April 2022 according to Civil Aviation Minister. Prior to the pandemic, domestic airlines carried 4 lakh passengers daily. While numbers began climbing after second wave, the Omicron variant again dampened sentiments. It is only since 18-Oct 2022 that airlines were allowed to operate at full capacity. Between Dec-21 and Jan-22, the average daily passenger flow fell 60% from 3.9 lakhs to 1.6 lakhs. Airlines reported net losses of Rs.19,000 crore in FY21.

Sumit Chanda

Sumit Chanda

Sumit has 18 years of experience in BFSI industry, into devising strategy for various functions, Investments and Managing Asset Portfolios. Specializes in Strategy & implementation in sales & operations, Team management, IT implementation, Affiliations.

Related Posts

Illustration of bullish and bearish market trends with digital bull and bear icons standing on stacked gold coins, promoting 6 multibagger stocks that surged in 2025. "Is your portfolio still in 2022?" – Jarvis AI

These 6 Multibagger Stocks Exploded in 2025 — Is Your Portfolio Still in 2022?

by Sumit Chanda
June 26, 2025
0
5.3k

In 2025, six multibagger stocks delivered explosive returns—while many investors were still stuck with outdated portfolios. Are you missing the...

Jarvis Invest blog - ‘Liquidity or Inflation? RBI Policy June 2025’ reflecting monetary policy focus

Liquidity or Inflation? RBI Policy June 2025

by Sumit Chanda
June 6, 2025
0
10

On June 6, 2025, the Reserve Bank of India took a bold step to revive economic momentum by slashing both...

Gold vs Stocks: Where should indians invest for better returns?

Gold vs Stocks: Where should Indians invest for better returns?

by Sumit Chanda
May 30, 2025
0
5.3k

As the world’s investment landscape shifts, investors often face the dilemma of where to park their funds for optimal returns....

NRI Investment Plan in India

How can NRIs invest Rs 50 lakh in India?

by Sumit Chanda
May 23, 2025
0
5.3k

When it comes to investment in India, Non-resident Indians (NRIs) are always skeptical about where to invest their hard-earned money....

Top 5 best growth stocks in India and sectors to watch in 2025

Top 5 Best Growth Stocks in India & Sectors to Watch in 2025

by Sumit Chanda
May 8, 2025
0
5.5k

You see the market correction in late 2024 and early 2025 was driven by weak economic data, corporate earnings misses,...

Best sectors to invest in 2025

India’s Fastest-Growing & Best sectors to invest in 2025

by Sumit Chanda
April 29, 2025
0
5.6k

In this blog, we are going to delve into the best sectors to invest in 2025 anticipated to experience the...

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Equity Market
  • Investing Basics
  • AI for investing
  • Trending Stock Market News: Quick Reads
  • Interesting Read
  • Financial Planning
  • Portfolio Management
  • Newsletter
Connect with us: customersupport@jarvisinvest.com

© 2023 Jarvis Invest

No Result
View All Result
  • CATEGORIES
    • Equity Market
    • Investing Basics
    • Interesting Read
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Newsletter
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner

© 2023 Jarvis Invest

Go to mobile version